Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TT3PRUG)

DTT Name	Cell division cycle protein 123 (CDC123)
Synonyms	Protein D123; HT-1080; PZ32
Gene Name	CDC123
DTT Type	Clinical trial target	[1]
UniProt ID	CD123_HUMAN
TTD ID	T63189
3D Structure	Download 2D Sequence (FASTA) Download 3D Structure (PDB) Download
Sequence	MKKEHVLHCQFSAWYPFFRGVTIKSVILPLPQNVKDYLLDDGTLVVSGRDDPPTHSQPDS DDEAEEIQWSDDENTATLTAPEFPEFATKVQEAINSLGGSVFPKLNWSAPRDAYWIAMNS SLKCKTLSDIFLLFKSSDFITRDFTQPFIHCTDDSPDPCIEYELVLRKWCELIPGAEFRC FVKENKLIGISQRDYTQYYDHISKQKEEIRRCIQDFFKKHIQYKFLDEDFVFDIYRDSRG KVWLIDFNPFGEVTDSLLFTWEELISENNLNGDFSEVDAQEQDSPAFRCTNSEVTVQPSP YLSYRLPKDFVDLSTGEDAHKLIDFLKLKRNQQEDD
Function	Required for S phase entry of the cell cycle. {ECO:0000250}.
KEGG Pathway	8872 (hsa )

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This DTT

1 Clinical Trial Drug(s) Targeting This DTT

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
SAR443579	DMF8W8F	Acute myeloid leukaemia	2A60	Phase 1	[1]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of Sanofi